RHUMBLINE ADVISERS - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 77 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,776
-27.1%
1,8300.0%0.00%
Q2 2023$6,551
-97.8%
1,830
-94.6%
0.00%
Q1 2022$294,000
-15.8%
34,046
+39.3%
0.00%
Q4 2021$349,000
-28.5%
24,435
+10.0%
0.00%
-100.0%
Q3 2021$488,000
+161.0%
22,223
+58.9%
0.00%
Q2 2021$187,00013,9820.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 8,355$61,0000.04%
TOCQUEVILLE ASSET MANAGEMENT L.P. 70,000$508,0000.01%
Financial Architects, Inc 2,000$15,0000.00%
FineMark National Bank & Trust 3,473$25,0000.00%
JFS WEALTH ADVISORS, LLC 1,000$7,0000.00%
Penserra Capital Management LLC 2,540$18,0000.00%
Tower Research Capital LLC (TRC) 1,284$10,0000.00%
SIMPLEX TRADING, LLC 2,673$19,0000.00%
Plante Moran Financial Advisors, LLC 300$2,0000.00%
Cutler Group LLC / CA 2,404$17,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders